| Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex C Xing, Y Zhuang, TH Xu, Z Feng, XE Zhou, M Chen, L Wang, X Meng, ... Cell 180 (4), 645-654. e13, 2020 | 245 | 2020 |
| Structural insights into the human D1 and D2 dopamine receptor signaling complexes Y Zhuang, P Xu, C Mao, L Wang, B Krumm, XE Zhou, S Huang, H Liu, ... Cell 184 (4), 931-942. e18, 2021 | 206 | 2021 |
| Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy J Duan, D Shen, XE Zhou, P Bi, Q Liu, Y Tan, Y Zhuang, H Zhang, P Xu, ... Nature communications 11 (1), 4121, 2020 | 171 | 2020 |
| Molecular recognition of morphine and fentanyl by the human μ-opioid receptor Y Zhuang, Y Wang, B He, X He, XE Zhou, S Guo, Q Rao, J Yang, J Liu, ... Cell 185 (23), 4361-4375. e19, 2022 | 159 | 2022 |
| Structures of the entire human opioid receptor family Y Wang, Y Zhuang, JF DiBerto, XE Zhou, GP Schmitz, Q Yuan, MK Jain, ... Cell 186 (2), 413-427. e17, 2023 | 106 | 2023 |
| Structure of formylpeptide receptor 2-G i complex reveals insights into ligand recognition and signaling Y Zhuang, H Liu, XE Zhou, RK Verma, PW de Waal, W Jang, TH Xu, ... Nature communications 11 (1), 1-12, 2020 | 106 | 2020 |
| Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor Q Liu, D Yang, Y Zhuang, TI Croll, X Cai, A Dai, X He, J Duan, W Yin, ... Nature chemical biology 17 (12), 1238-1244, 2021 | 80 | 2021 |
| Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor Y Zhuang, B Krumm, H Zhang, XE Zhou, Y Wang, XP Huang, Y Liu, ... Cell research 31 (5), 593-596, 2021 | 72 | 2021 |
| Structure of the PRC2 complex and application to drug discovery Y Shi, X Wang, Y Zhuang, Y Jiang, K Melcher, HE Xu Acta Pharmacologica Sinica 38 (7), 963-976, 2017 | 70 | 2017 |
| Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor Y Wang, S Guo, Y Zhuang, Y Yun, P Xu, X He, J Guo, W Yin, HE Xu, X Xie, ... Nature communications 12, 2021 | 64 | 2021 |
| Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2 Y Zhuang, L Wang, J Guo, D Sun, Y Wang, W Liu, HE Xu, C Zhang Nature communications 13 (1), 1054, 2022 | 56 | 2022 |
| Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins Y Wang, W Liu, Y Xu, X He, Q Yuan, P Luo, W Fan, J Zhu, X Zhang, ... Nature Chemical Biology 19 (11), 1351-1360, 2023 | 28 | 2023 |
| Development of “plug and play” fiducial marks for structural studies of GPCR signaling complexes by single-particle cryo-EM P Dutka, S Mukherjee, X Gao, Y Kang, PW de Waal, L Wang, Y Zhuang, ... Structure 27 (12), 1862-1874. e7, 2019 | 23 | 2019 |
| Structural genomics of the human dopamine receptor system P Xu, S Huang, BE Krumm, Y Zhuang, C Mao, Y Zhang, Y Wang, ... Cell Research 33 (8), 604-616, 2023 | 20 | 2023 |
| C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels Y Shi, H Ma, Y Zhuang, X Wang, Y Jiang, HE Xu Acta Pharmacologica Sinica 40 (11), 1457-1465, 2019 | 11 | 2019 |
| Structural basis of psychedelic LSD recognition at dopamine D1 receptor L Fan, Y Zhuang, H Wu, H Li, Y Xu, Y Wang, L He, S Wang, Z Chen, ... Neuron 112 (19), 3295-3310. e8, 2024 | 1 | 2024 |
| Molecular basis for the activation of PAF receptor by PAF W Fan, Y Xu, X He, P Luo, J Zhu, J Li, R Wang, Q Yuan, K Wu, W Hu, ... Cell Reports 43 (7), 2024 | 1 | 2024 |
| Structural basis for ligand recognition and G protein-coupling promiscuity of the cholecystokinin A receptor Q Liu, D Yang, Y Zhuang, TI Croll, X Cai, A Dai, X He, J Duan, W Yin, ... bioRxiv, 2021.05. 09.443337, 2021 | 1 | 2021 |
| Structural insights into the agonist activity of the nonpeptide modulator JR14a on C3aR P Luo, W Xin, S Guo, X Li, Q Zhang, Y Xu, X He, Y Wang, W Fan, Q Yuan, ... Cell Discovery 11 (1), 7, 2025 | | 2025 |
| Selective ligand recognition and activation of somatostatin receptors SSTR1 and SSTR3 Y Wang, Y Xu, Y Wang, J Zhang, L Chen, X He, W Fan, K Wu, W Hu, ... Proceedings of the National Academy of Sciences 121 (41), e2400298121, 2024 | | 2024 |
H Eric Xu (徐华强), ProfessorShanghai Institute of Materia Medica, CAS; Tsinghua; Duke; UTSW; MIT; VARI/GlaxoWellcome/GSKVerificeret mail på simm.ac.cn
